Howard J. Federoff's Insider Trades & SAST Disclosures

Howard J. Federoff's most recent trade in Eterna Therapeutics Inc was a trade of 413,700 Stock Option (Right to buy) done . Disclosure was reported to the exchange on March 11, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eterna Therapeutics Inc
Howard J. Federoff Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2022 413,700 413,700 - - Stock Option (Right to buy)
Eterna Therapeutics Inc
Howard J. Federoff Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Apr 2021 2,627,915 2,627,915 - - Stock Option
Eterna Therapeutics Inc
Howard J. Federoff Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Apr 2021 597,253 597,253 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades